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ABSTRACT
A COMPARATIVE STUDY OF COMMON CROSSLINKINGING AGENTS FOR
ELECTROSPUN COLLAGEN SACFFOLDS
by
Pallavi Masih
Cartilage injury is one of the leading causes of knee pain in the world. Over two million
Americans suffer from cartilage injury every year, resulting in swelling, pain or joint
impairment, causing it difficult to maintain an active life style. Synthetic grafts are used
extensively to restore tissue functions. The major drawback limiting successful
incorporation of synthetic grafts in body is their lower ability to integrate to natural
tissue, poor biocompatibility which often results in triggering immunogenic responses,
causing graft rejection. Collagen is thus studied and used excessively as a successful
implantable material. The reason being that it is natural in origin, biocompatible,
bioresorbable, easily available and very cost effective. The current study involves
electrospinning of type I collagen fibers extracted from bovine tendons and to modify
their properties by various crosslinking methods using glutaraldehyde, genipin, or N-(3Dimethyl aminopropy1)-N'-ethyl carbodiimide with and without Nhydroxysulfosuccinimide. The fibers were characterized using both chemical and
physical tests to compare the effectiveness of different crosslinker and crosslinking
concentrations. The tests involved mechanical testing using instron, determination of
thermal stability using DSC, surface and morphological analysis using SEM, measure
of free amino acid to determine crosslinking density. The genipin crosslinked samples
were comparable in morphology and more thermally stable than EDC crosslinked
samples.
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CHAPTER 1
INTRODUCTION

1.1 Objective
Cartilage injury is one of the leading causes of knee pain in the world. Over two million
Americans suffer from cartilage injury every year, resulting in swelling, pain or joint
impairment, making it difficult to maintain an active life style. The reparative surgery
assures to restore 85% to 90% of stability and joint mobilization but an extrapolation of
these results showed a post-operative failure rate of 10% to 15% [2]. The most common
causes of chronic knee pain and disability are arthritis, osteoarthritis, rheumatoid arthritis,
and traumatic arthritis [3].
Cartilage injury is characterized by mechanical deformations in the connective
tissue layer covering the bone surface in joints. The degeneration of tissue may be caused
due to swelling in synovial membrane, ACL tear, osteohchondral fracture or softening of
chondral tissues. A study of 25,124 conducted by W. Widuchowski et al. of knee
arthroscopies performed from 1989 to 2004 showed cartilage defect to be cause of knee
pain in 60% of the cases, and the numbers are still increasing [44]. The major limitations
for the healing of cartilage are avascular, aneural nature of the tissue which limits the
supply of blood and nutrients required for new tissue growth and the complex,
multidirectional forces which it is subjected to. It has been difficult to tissue engineer a
scaffold which can mimic the natural ECM architecture, degrade at a rate that matches
new tissue generation rate and physically withstand the load which the initial tissue was
subjected to prior to injury. Currently the most commonly employed tissue engineering
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approach involves ex-vivo growth of chondrocytes on bioactive scaffolds which can
stimulate tissue generation along with providing the base for cell attachment and reimplantation within patient's body. The procedure is known as Autologous Chondrocyte
Implantation (ACI). Out of 855 prosthetic ligaments tracked for 15 years, 40-78% of the
implants failed due to foreign body inflammation, particulate induced synovitis, wear
debris and mechanical limitations [1]
The goal of this project is to develop scaffolds which can mimic the extra-cellular
matrix (ECM) architecture within cartilage, and maintain its structural integrity under
physiological conditions for a duration needed to regenerate biological tissue. This
project will include the fabrication of these scaffolds and enhancement of its
physiochemical properties to support cellular responses. Assessment of the scaffold's
physicochemical and mechanical properties will be performed.

1.2 Background Information
The articular cartilage is a dense fibrous connective tissue which consists of a highly
specialized extra-cellular matrix suspended with cartilage producing cell: chondrocytes,
water (about 80%), collagen and proteoglycans (GAGs). The collagen and GAGs offer
elasticity, mechanical strength and wear resistance to the tissue. Cartilage has an average
breaking load of 2160N and a stiffness of 242 N/mm and absorb 12.8Nm energy during
failure [1, 9, 11]. Young's modulus of human ACL was found to be 111MPa and ultimate
tensile strength of 38MPa [1]. However, during physiological loading it is typically
loaded to only 10-25% of its breaking load [10, 11]. ACL is exposed to tensile forces
ranging from 67N to 630N for daily activities [1]. Cartilage is responsible to reduce
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friction by lubricating the joint, facilitate movement, withstand mechanical load and
provide wear resistance.
Articular cartilage injury can occur because of two reasons, traumatic mechanical
destruction which results from direct blow or trauma during sports or other activity
causing anterior cruciate ligament tear or osteochondral fracture. Secondly, it can occur
as a result of progressive wear and tear due to disease of the chondral tissue which causes
softening of cartilage or inflammation and swelling of synovial membrane producing
excessive synovial fluid, over-filling the joint space resulting in pain, restricted joint
movement and loss of cartilage. It is sometimes possible for the cartilage cells to repair
itself depending on the site of injury and extent of damage, but it takes a longer healing
time and may lead to formation of scar tissues. Statistics show that in the United States
alone sports injuries account for 28% of all knee injuries [2].
The traditional techniques to repair cartilage injury include (a) micro-fracture
which involves drilling a hole through the injured cartilage to the underlying bone to
enhance the supply of blood which could promote tissue repair; (b) arthroscopic
chondroplasty in which the surgeon trims away the loose and damaged cartilage, reduces
pain but complete healing is not ensured; (c) osteochondral autograft involving
implantation of healthy cartilage from region of lower loading to site of injury within the
same patient; (d) autologous cartilage implantation with involves ex-vivo growth of
chodrocytes and re-implantation within the same patient; (e) osteochondral allograft
involves implantation of freshly donated cadaver cartilage.
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1.2.1 Role of Tissue Engineering and Stem Cell Research for Cartilage Repair
"Tissue engineering is an interdisciplinary field which applies the principles of
engineering and life sciences towards the development of biological substitutes that can
restore, maintain, or improve tissue function" [13]. The three basic approaches adopted
for the regeneration of tissues include: (a) isolated cells implanted at the site of injury, (b)
a biomaterial scaffold on its own, (c) cells seeded in the scaffold matrix.
The first approach involves extraction of healthy cells from donor site, ex-vivo
growth of these cells in physiological fluid and re-implantation of matured cells to the
site of injury. The approach is most commonly applied for the repair and regeneration of
soft-tissues, as it eliminates any risk of graft rejection due to immune response, which is
one of the greatest challenges in the field of tissue engineering.
The second approach involves implantation of a biomaterial scaffold at the site of
injury which will provide a ground for cell attachment, migration, proliferation and
differentiation and will gradually get replaced by natural tissue over time. In this project,
the author aims for the design of an optimum scaffold that mimics natural tissue
architecture, mechanical strength and maintains structural integrity in physiological fluid
over time. The last approach involves seeding of cells within the scaffold matrix prior to
implantation.
A study conducted at the University of Bristol showed that an engineered
cartilage tissue can grow and mature when implanted into patients with a knee injury
[14]. The study involved re-implantation of cultured cells, harvested from healthy
cartilage grown for 14 days on hyaluronic acid scaffold prior to implantation. The
material for cell growth and implantation thus plays a critical role in determining the fate
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of tissue repair and regeneration. Scientist from Imperial Collage London in 2005, have
successfully converted human embryonic stem cells into cartilage cells. The study
involved implantation of differentiated embryonic stem cells seeded within a bioactive
scaffold in rat model which matured into cartilage cells after 35 days [21]. A similar
study was conducted at Rice University in 2007 to successfully convert embryonic stem
cells into cartilage cells after seeding on a bioactive scaffold [22].
The demand placed on materials used in tissue engineering varies depending on
the implantation site and tissue being replaced [15]. The design of a scaffold that
promotes cartilage regeneration requires that (a) the structure replicates the ECM
architecture and strength of native tissue, (b) facilitate cell infiltration, (c) and biodegrade
at a rate that matches the rate of new tissue formation [11, 15, 16]. The most widely used
biomaterials in tissue engineering are polylactic acid (PLA) and polyglycolic acid (PGA)
and their copolymers, synthetic in nature and collagen, which is natural in origin.
Polymers allows for controlled degradation rate and mechanical properties, as well as
surface modification for binding of surface reactive factors to promote cell growth or
inhibition.
Collagen is the most commonly used biomaterial for connective tissue repair and
regeneration [11, 15, 16, 17, 18, 19, 20]. It is also widely applied in medical and
pharmaceutical applications. It is a fibrous protein, natural in origin which has adhesive
peptides and integrin-binding domains that promote cell adhesion, migration,
proliferation and differentiation. It is biocompatible and hemo-static in nature and can be
surface modified to eliminate the surface bound antigens which might elicit an
inflammatory immune response causing graft rejection which is one of the major

6
challenges in tissue engineering.

1.2.2 Collagen Overview
The collagen word derives from Greek word "kolla", which means "glue". There are
more than 20 different types of collagen identified in the body. It is a fibrous protein,
which constitute about 30% of the total body proteins including skin, bones, tendon,
cartilage, ligaments and blood vessels.
It is the basic component of all connective tissues and is dispersed in the ECM in
large quantities [19]. The specific amino-acid sequences on its surface favors cell
adhesion, proliferation and differentiation. It provides flexibility, mechanical strength,
wear resistance, resilience to bones and tendons, elasticity to blood vessels and skin and it
acts as a scaffold for cellular attachment and tissue growth as a component of the ECM.
Although the collagen in skin, blood vessels, bones, tendons and ligaments are all similar
in structure and composition, the variation in their properties is caused due to slightly
different amino-acid content, amino-acid sequence and their location on the backbone
chain.
Collagen is the most abundant protein in animal kingdom and thus is available in
abundant supply and can be efficiently extracted from bovine, porcine skin or tendons
[19]. The extracted collagen is then purified by enzymatic treatment and chemical
washes. The purified collagen can further be processed into fibers, sponges, gels or films
by extrusion, lyophillization, casting and other processing techniques. The properties of
collagen which make it an efficient biomaterial in medical and pharmaceutical industry
are its cell-binding capability, high mechanical strength, non-antigenicity,
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biocompatibility and biodegradability.
The resorption rate of collagen depends on its inter- and intra-molecular
crosslinking and it can be varied from days to weeks to a non-degrading stable structure
by various physical and chemical treatments. The basic framework of collagen [Figure
1.1] constitute a triple helical structure composed of subunit of collagen, known as the
pro α-chain, which is coiled together in a right-handed helix. These collagen fibers are
assembled together into larger units giving hierarchy to form tendons, ligaments, bones
and alike.
Amino acid

30nm
Tropclagen

Fibril ~ 1 am

Fiber ~ 10um

Figure 1.1 The hierarchy of collagen fiber.
[Source: http://images.google.com/images?h1=en&q=tropocollagen&bMG=Search+Image]
An individual α-chain is approximately 1050 amino-acid residue in size. It
consists of a repeating sequence of glycine-proline-hydroxyproline residues. There are
3.3 amino-acid residues per turn and 2.9°A per amino-acid residue. During the physical
or chemical treatment the crosslinks between the amino-acids increases, causing an
increase in the tensile strength and denaturation temperature while decreasing the water
uptake capacity and degradation rate of collagen.
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1.2.3 Collagen Synthesis
The synthesis of collagen begins in the membrane bound ribosome's, which secrets the
pro-a chain into the endoplasmic reticulum. Each a-chain consists of a repeating
sequence of gly-pro-hydroxy-X amino-acids [Figure 1.2], where 'X' is any amino-acid
attached to the side-chain. The glycine being the shortest amino-acid is responsible for
the tight bonding between adjacent side-chains. It consists of about one-third of the
residue. Proline is an aromatic amino-acid which stabilizes the helical bonding within
collagen. It constitutes about 13% of the residue, while hydroxyproline is nearly 10%.

Figure 1.2 Major amino-acids of collagen: hydroxylysine, proline, hydroxyproline and
glycine [6].

In the endoplasmic reticulum, the lysine and proline hydroxylate, and depending
on the nature of the amino-acid attached at hydroxyl- end, will form hydroxylysine or
hydroxyproline. The percentage of proline and hydroxyproline affects the stability of
collagen structure. The hydroxyproline molecule thermally stabilizes the collagen
molecule. Each pro a-chain sub-unit consists of amino- (N-terminal) and carboxyl- (Cterminal), which are additional amino-acids on either side known as propeptides, with
open-ends to form crosslinks. The individual tropocollagen molecule is approximately
300nm in length and 1.5nm in diameter. Each a-chain consists of about 1000 amino-acid
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groups [31]. The α-chain combines with other two to form a hydrogen-bonded, righthanded, triple-helical structure, known as procollagen molecule [Figure 1.3].

Figure 1.3 The procollagen molecule: building block of collagen fiber [7].

The procollagen molecule is secreted out of the lumen, which converts the
procollagen molecule to collagen molecule by the cleavage of propeptides by specific
proteolytic enzymes.
SYNTHESIS Of PRO

Figure 1.4 The synthesis of collagen fiber from procollagen molecule [7].
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The collagen molecules assembles together to form collagen fibril, as shown in
Figure 1.4. The structure is stabilized by covalent and hydrogen bonds. The mechanical
strength, elasticity, wear resistance of different tissues varies with variation in the extent
of crosslinking of collagen fiber within the tissue structure. Figure 1.5 shows the various
crosslinks which exist within the native collagen structure providing the mechanical
strength, elasticity, streachability and wear resistance. Intra-helical bonds
present between within the helical chain, inter-helical bonds

(~4nm)

(~1.5nm)

are

link two or more

chains together. Inter-microfibrillar bonds are present over a larger range of 1.3~ 1. 7nm
which links neighboring side chains. The type of bond formed affects the physiochemical
nature of collagen. Inter- and intra-helical bonds increases the denaturation temperature
and resistance against enzymatic degradation, improving the stability of crosslinked
structure. The inter-microfibrillar bond improves the mechanical strength. EDC can

"
crosslink fibers within 1nm of range (inter- and intra-helical bonds}'while
genipin can
f

bond fibers 1.6 to 2.5nm apart [30].

lntennicrofibrillarcross- link

I ))))

)

Collagen tiber

Interhelical cross-Iuik

Figure 1.5 The Intra- and Inter-helical crosslinking within collagen molecule [30].
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The collagen fiber has a young's modulus of 111MPa, yield stress of 50MPa and
10% yield strain. The strength and architecture of collagen fibers varies within different
tissue or organs [Figure 1.6]. They are arranged as long rope-like bundles in tendons and
ligaments to offer elasticity and flexibility; meshed web-like structure in the structure of
skin and blood vessels to offer elasticity and wear resistance; stacked in form of tiles, one
over another in bones and cornea (Figure 1.6). In cartilage the collagen fibers are
arranged in form of a meshwork with the glycoaminoglycans (GAGs) dispersed
throughout the matrix. The GAGs are responsible for absorbing water like sponges, and
releases when loaded, which keeps the joint lubricated and facilitates movement.
CI

Figure 1.6 The various arrangement of collagen fibers: cartilage (meshed web with
GAGs suspended), bones (stacked), skin (web-like), tendon (rope-like). [Source:
http : //images. goo gle. com/image s?gbv=2&h1=en&q=co llag en%2C+tendon&btnG=Search
+Images]

Collagen degrades over time but the rate of turnover varies among different
tissues. It might range from few days in skin to approximately 10 years in bone.
Collagenase is the naturally occurring enzyme responsible for breakdown of collagen
fibers within tissues. Age, injury, genetic disorder stimulates the degeneration rate and
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results in slower healing of tissues.
Statistics shows that more than 225,000 people worldwide underwent
arthroscopic meniscal repair in 2002, and the number of procedures is expected to have a
compound annual growth rate of nearly 5% through 2007 [4]. The continuously
increasing demand necessitates the development of new techniques to repair and
regenerate tissues to avoid total joint replacement. The goal of this project is to fabricate
collagen scaffolds in a web-like architecture which mimics the extra-cellular matrix
within native tissue and maintain stable structure to support tissue regeneration.

1.2.4 Collagen Scaffold Fabrication
Collagen scaffolds are of extreme interest in tissue engineering as they provide the base
for cellular growth. They mimic the biochemical and structural architecture of the ECM
of tissues, which can influence cell behavior [18, 32, 33]. Electrospinning is a processing
technique that provides an efficient way to generate a meshed web-like structure of
collagen fiber having nanometer to micron diameter scale fibers which would closely
resemble the ECM architecture of native tissue [17].
The spinning set-up consists of a syringe-pump, voltage supplier and a metal plate
(as shown in Figure 1.7). The syringe is filled with the polymer solution and is mounted
on the syringe-pump assembly. The syringe-pump pushes the fluid through syringe at a
selected flow rate. A metal plate is placed on the opposite end. The syringe needle and
the metal plate are connected to a voltage supplier which can be regulated to maintain a
desired potential difference between the two.
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The fluid coming out of the needle is pulled towards the metal plate, due to the
potential difference applied. The fluid droplet experience a pull outwards and deforms to
a pyramidal shape at the needle tip, known as taylor cone. At a certain level, the droplet
overcomes the surface tension of the viscous fluid, and starts drawing towards the metal
plate. The droplet thus extends to form a fiber which gets dried in the air due to solvent
evaporation, before it reaches the metal plate. The fiber thus formed, gets deposited on
the metal plate forming a meshed web-like structure of randomly oriented fibers.

Dry,Fives

Polymer Solution

Syringe
Syringe Pump

e e dle
Taylor Cone

High Voltage
Supply

Metal Plate
Ground

Figure 1.7 The set-up for electrospinning of collagen scaffolds.
[ Source: http://www.che.vt.edu/Wilkes/electrospinning/Slide 1 . JP G]

The factors which affect the fiber geometry are: needle diameter, electric voltage,
distance between metal plate and needle tip, flow rate and polymer concentration. By
varying these factors, the fiber diameter can be varied from nano to micron range. An
increase in needle diameter, fluid concentration, flow rate and voltage would increase the
fiber diameter size while increasing distance would inversely decrease the fiber diameter.
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A few other factors that affect the fiber formation are: humidity, temperature and
air flow. A higher humidity would slower the rate of solvent evaporation, leading to
beads formation embedded within or on the fibers. The spinning procedure during the
project was thus carried out in an environment chamber with vacuum, to minimize
formation of any beads and obtain uniform fiber geometry.
A scaffold must mimic the ECM architecture and properties. The structural
requirements include high-matrix porosity, stability, small fiber diameter and a threedimensional structure to allow cell-infiltration [17]. The electrospun collagen fibers
consist of reconstituted collagen fibril but are fragile in nature, due to lack of native
crosslinks and dissolves instantaneously in water, unlike native collagen which does not
dissolve. Thus, collagen fibers need to be physically or chemically modified to increase
their stability, reduce the water uptake and lower the degradation rate. Collagen
electrospun mats immediately disintegrates and dissolves in an aqueous medium due to
bonding of free amines with hydrogen molecule [18, 34].

1.2.5 Physical Modification of Collagen Mats
The most commonly used physical methods to crosslink collagen fibers include
dehydroxy-thermal (DHT) treatment and ultra-violet light (UV) exposure. The collagen
fibers are heated under atmospheric pressure to a temperature above 105°C for DHT, to
dehydrate the structure.
The removal of water molecule forms amide bonds and brings a-chains more
closely to one another thereby increasing the crosslinking within the structure. The
duration of exposure and heat supplied determines the extent of crosslinking. Irradiation
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to UV rays (254nm) offers another approach to physically crosslink collagen scaffold
where the degree of crosslinking depends on the extent of penetration of exposed
radiations.
Physical crosslinking technique offers advantage of lesser risk for toxins release
in the physiological fluid as no chemicals are involved during crosslinking. The physical
crosslinking methods increase the mechanical strength of collagen fibers higher than
chemical methods but they also induce denaturation of a portion of the collagen molecule
which may affect cell attachment, proliferation and differentiation [16, 19].

1.2.6 Chemical Modification of Collagen Mats
Chemical crosslinking has been widely used in leather and pharmaceutical industry since
decades. The most commonly used crosslinking reagents for biological tissues are
glutaraldehyde, formaldehyde, diisocynates and epoxy compounds [18, 31]. The
chemical crosslinking can be classified on the basis of (a) origin of crosslinker:
synthetic/natural and (b) method of crosslinking: vapor/liquid.

Table 1.1 Various Crosslinking Reagents and Methods Used
Crosslinking reagent

Origin

1. Glutaraldehyde

Synthetic

Vapor crosslinking at room temperature

2. EDC

Synthetic

Liquid crosslinking at room temperature

3. EDC with NHS

Synthetic

Liquid crosslinking at room temperature

4. Genipin

Natural

Liquid crosslinking at body temperature

Method for crosslinking
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Glutaraldehyde is an oily-colorless liquid at room temperature, miscible in water
[16]. It is widely used in manufacturing industries for sterilizing medical and dental
equipments, in water treatment or as chemical preservatives. It is highly corrosive and
vaporizes easily in atmosphere. Figure 1.8 shows the chemical structure of the
glutaraldehyde molecule.

Figure 1.8 Glutaraldehyde molecule [31].

The collagen mats were vapor crosslinked using glutaraldehyde. The crosslinking
set-up consisted of a beaker filled with glutaraldehyde solution, covered with an
aluminum foil, to avoid any release of glutaraldehyde residues in the ait"[Figure 1.9]. The
f

mats were placed on the meshed polymer sheet, ensuring complete and uniform exposure
to the vapors.

Meshed
Screen

Ele ctro spun mat
\ '

Glutaraldehyde
solution

Figure 1.9 Schematic of the vapor crosslinking set-up used in the study [17].
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The mats were allowed to crosslink for the desired period of time. The
crosslinking was followed by rinsing in DI water to remove un-reacted aldehyde residues.
During the glutaraldehyde crosslinking [Figure 1.10], the aldehyde group reacts with
amino groups of lysyl and hydroxylysyl residues in collagen, coupled with release of a
water molecule and Schiff based intermediates are formed which links further to form
larger crosslinked entities [17, 39, 41].

Figure 1.10 The crosslinking mechanism of glutaraldehyde: condensation reaction
[Source: http://arthritis-research.com/content/figures/ar2202-2.jpg].

Glutaraldehyde offers the advantage of being less expensive, faster reaction time,
crosslinks a large number of amino acid groups present in protein molecule over a
varying range of distance [18]. The major drawback for the use of glutaraldehyde is that
it causes local toxicity at the site of implantation due to release of un-reacted aldehydes
[19]. Previous studies have shown a significant increase in mechanical strength and
denaturation temperature for tissues crosslinked with glutaraldehyde but have noted
calcification over time [18, 31, 39, 41].
The second crosslinker used for this study was N-(3-Dimethyl aminopropyl)-N'ethyl carbodiimide hydrochloride (EDC) (Figure 1.11). It is a zero-length which means
the agent itself is not incorporated in the macromolecule; water-soluble, synthetic reagent
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[19]. The protonated carbodiimide links the amine to the carboxylic acid group of
glutamic and aspartic amino acid of protein molecule, forming an amine-reactive 0acylisourea intermediate.

Figure 1.11 EDC (1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide) molecule [30].

The 0-acylisourea undergoes a nucleophilic attack by the amine functional group
of lysine and hydroxylysine and peptide crosslinks are formed bridging the neighboring
polypeptide chains, as shown in figure 1.12. The intermediate formed is in an unstable
form and may hydrolyze back to regenerate carboxyl group if not interacted with an
amine group.

Figure 1.12 Crosslinking mechanism for EDC.
[Source: http://arthritis-research.com/content/figures/ar2202-2.jpg].

Secondly, they may rearrange themselves to form N- acylurea group, which is
more stable in nature and is attached to the modified peptide, thus lowering the
crosslinking efficiency of EDC.
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The crosslinking efficiency of EDC can be improved by addition of Nhydroxysulfosuccinimide (NHS), shown in figure 1.13, which reacts with the 0acylisourea intermediate to form NHS reactive NHS-ester coupled with the release of 1ethyl-3(3-aminopropyl) urea (EDU) which can be removed by rinsing [18, 34]. The NHS
also reacts with the free amino groups and forms peptide crosslinks which are more stable
in nature. Figure 1.14 shows the mechanism for crosslinking of collagen with EDC and
NHS.

Figure 1.13 (N-Hydroxysulfosuccinimide) molecule [30].

The addition of NHS prevents the rearrangement of intermediates and formation
of side products. The 0-acylisourea group is converted into NHS-activated carboxylic
acid group which is less susceptible to hydrolysis [30]. Thus, addition of NHS increases
the rate of reaction and results in an efficient crosslinking [9, 18, 35].

Figure 1.14 The crosslinking mechanism of collagen with EDC and NHS both [18].
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The byproduct of EDC is a compound of urea (EDU) which gets eliminated from
the body through an enzymatic pathway ensuring no toxic effect on cells or tissues,
improving biocompatibility of EDC treated grafts. The carbodiimide can link groups
located within 1.0 nm range and thus can form inter- and intra-molecular crosslinking
only but not inter-microfibrillar, as the micro-fibrils are too apart (1.3 to 1.7nm) for EDC
bridging [30].
Since electrospun collagen dissolves in an aqueous medium, ethanol was used as
a common solvent for EDC and EDC with NHS crosslinking. Ethanol is a watermiscible, non-aqueous solvent which has been previously used with collagenous material
without denaturation of the collagen or cytotoxicity [18]. The ethyl group reacts through
hydrophobic interaction with the collagen surface, while the hydroxyl group binds with
other through hydrogen bond forming a polymeric chain, which all together stabilizes the
collagen structure and explains the maintenance of its structural integrity with little or no
shrinkage [17, 18, 36, 37].
Genipin and proanthocyanidin are some of the natural crosslinkers previously
used for biological tissue fixation [39]. The current study employs genipin as the third
reagent for collagen fibrous mat crosslinking. Genipin is a naturally occurring
crosslinking agent which can be extracted from the fruit of Gardenia Jasminoides Ellis
[30, 31, 39]. In the plant, it is responsible for germination and growth inhibiting
activities. It is colorless in nature but forms a blue color stain when reacted with aminoacid [27]. Figure 1.15 shows the molecular structure of genipin.
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Figure 1.15 The molecular structure of genipin [30].

It is used in Chinese medicine to treat ulcer of skin, jaundice, acute conjunctivitis,
epistaxis, hematemesis, pyrogenic infections, and externally on sprains and painful
swelling due to blood stasis [27, 31, 39]. It is also used as food colorant in East Asia and
fingerprinting dye in forensic science [43]. "The structure of genipin was first discovered
by Djerassi and his colleagues in 1960's" [27].
The genipin crosslinking is comparatively slower than glutaraldehyde or
carbodiimide crosslinking [30]. The genipin reacts through a nucleophilic reaction
between the primary amine groups on C3 carbon on backbone structure [Figure 1.16].
The nucleophilic reaction opens the dihydropyran ring causing crosslinking between
aldehyde groups in the secondary amine, followed by dimerization produced as a result of
radical reaction to form nitrogen-iridoid which undergoes dehydration to form aromatic
monomer [30, 39, 41]. A blue color pigment is produced as an end-product of the
reaction of genipin with methylamine, as studied by Touyama et al. [42].
Genipin can bridge peptide chains 1.6 nm to 2.5 nm apart, and thus can form
inter-, intra-helical and inter-microfibrillar crosslinks by genipin polymerization [27, 30,
38, 39]. It has been speculated that genipin crosslinked gelatin are 10,000 times less
cytotoxic than glutaraldehyde crosslinked gelatin or biological tissues, without any sign
of calcification [27, 31, 41].
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Figure 1.16 The crosslinking mechanism for genipin
[Source: http://arthritis-research.com/content/figures/ar2202-2.jpg].
It is a biodegradable molecule with low cytotoxicity and is actively employed for
crosslinking of gelatin for wound dressing, bioadhesives, bone substitutes and nerve
guides [27]. Although genipin has been widely used for crosslinking of natural tissues, no
previous work demonstrates the use of genipin to crosslink electrospun collagen fibers.
The present study documents the generic protocol to crosslink electrospun pure type I
collagen fibers with genipin.
The study further proceeded to compare the effectiveness of all three crosslinking
reagents with respect to one another. The results were compared on the basis of fiber
diameter, denaturation and glass transition temperature, dimensional and weight changes,
free amino-acid content and stability in physiological fluid at body temperature over a
period of 3 months.

CHAPTER 2
MATERIALS AND METHODS

2.1 Method Optimization
In this project, the author's endeavor was to create a uniform small diameter, porous
collagen scaffold with sufficient strength such that it can maintain its structural integrity
under physiological conditions for a duration that ensures tissue regeneration in vivo.
-

Collagen fiber mats were fabricated using electrospinning and crosslinked with three
different crosslinkers to improve their stability and reduce degradation rate. The
parameters for electrospinning of the collagen scaffolds were optimized. The
concentrations for the crosslinking agents were also identified. The final samples were
tested for physicochemical properties by studying dimensional and weight changes,
variation in denaturation and glass transition temperature, porosity, fiber diameter and
percent of free amino-acid content. The mechanical strength was analyzed using instron.
The mats were incubated in phosphate buffer solution at body temperature to mimic
physiological conditions and were harvested at time points of 1 month, 2months and 3
months.
2.1.1 Electrospinning Process
The following electrospinning parameters were optimized to obtain uniform fiber
scaffold ranging from few hundred nanometers to 2-3 microns, without formation of any
beads. The smaller diameter range fibers would closely mimic the ECM architecture and
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could thus enhance cellular attachment, proliferation and differentiation when used for
cellular study [4]. The electrospinning parameters used in the current study are: a 20
gauge needle, 42.85% (by weight) collagen solution, 20 KV electric voltage, 0.02 ml/min
flow rate, and a 40 cm distance between needle and metal plate.

2.1.2 Optimization of Crosslinking Concentrations
In the study by Cheryl et al., two glutaraldehyde concentrations of 1.5% and 0.5% were
used [17]. The 0.5% crosslinked mats maintained better fiber geometry after crosslinking
as compared to 1.5%. The crosslinked samples turned yellowish red in color, shrunk and
gelled in water based medium. The above finding matched the results found in [17]
which concluded 0.5% of glutaraldehyde was a sufficient concentration to crosslink
electrospun collagen fibers. Thus, the study proceeded with 0.5% of glutaraldehyde
concentration to crosslink collagen fiber mats.
Catherine E.Barnes in her study compared four different EDC concentrations for
crosslinking type II collagen electrospun mats used for cartilage repair [18]. The
elctrospun mats were crosslinked using 20mM and 200mM of EDC compared with
20mM of EDC with 20mM NHS and 200mM of EDC with 200mM NHS in ethanol. The
study concluded 20mM EDC crosslinked samples were not statistically different from
non-crosslinked samples, while 200mM EDC and 200mM of EDC with 200mM of NHS
imparted desirable mechanical strength maintaining fibrous structure of the electrospun
mats. Thus, in this study, these two concentrations were further compared on the basis of
stability in PBS at 37°C, free amino-acid content, dimensional and weight change,
porosity and mechanical strength.
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Genipin have been previously used to crosslink biological tissues and collagen
gels at concentrations 0.625% to 1% but had not been used until recently for crosslinking
of electrospun collagen mats [39, 40, 41]. It has been used previously to crosslink
chitosan at concentrations of 5%, 10%, 20% and 30% for disk tissue engineering [42].
The genipin has been of extreme interest for crosslinking because it is natural in origin
and has shown no cytotoxic effect on the biological tissues [39]. The current study
developed a new technique to crosslink electrospun collagen mat using genipin. The
greatest challenge to crosslink collagen mats was maintaining their structural integrity
when placed in crosslinking medium. Pure collagen dissolves immediately when placed
in water based medium, which is the common solvent for most of the crosslinking
reagents. Electrospun collagen fiber scaffold does not dissolve in ethanol [18]. The
genipin was thus dissolved in ethanol and the standard crosslinking protocol of
immersion for 3 days at body temperature was used as followed in previous studies for
crosslinking tissues [40].
The various concentrations tried for crosslinking of collagen mats included: 1% to
10%, 20%, and 30% by weight. The crosslinked mats were air dried and viewed under
light microscope for fibers. They were immersed in PBS at room temperature to check
for stability of mats in water based medium after crosslinking. The 20% and 30%
crosslinked mats showed no distinguishable fibers, probably due to excessive
crosslinking, causing fibers to merge into one another. The 1% to 4% crosslinked mats
dissolved in PBS within 10 days of immersion.
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Based on the above findings, 1%, 5% and 10% were selected to carry out further
studies. The immersion study was conducted at body temperature instead of room
temperature to more closely mimic the physiological environment and predict the
scaffold behavior when placed in cell medium to grow cells. The duration of the
immersion study was 3 months with samples harvested after every 1 month.

2.2 Collagen Purification
Pure type I insoluble collagen was purified from bovine tendons by various enzymatic,
alkaline and acidic treatments. The frozen bovine tendons (approximately 1000g) were
first cleaned manually and later chopped and grinded using an electric deli meat grinder.
The grinded tendon was treated with enzyme (ficin) dissolved in potassium phosphate
monobasic buffer at a pH of 6.15+ 0.15 (37°C). Ficin attacks the peptide bond and
removes blood or protein components present, which are potent of transferring xeno-graft
diseases. The enzyme was deactivated by alkali treatment of sodium hydroxide and
anhydrous sodium sulphate solution for 42 hours. The alkali was later washed-off by
repeated washing in anhydrous sodium sulphate solution and sulfuric acid at a pH 4.6.
The purified collagen bundles were sterilized by isopropanol treatment at 60°C followed
by drying in oven overnight at 45°C.
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2.3 Electrospinning of Collagen Mats
The electrospinning of collagen involves three basic steps: solvent preparation, spinning
of collagen fibers, drying and storage. The solvent was prepared in fume hood, and the
spinning was carried out in an environmental chamber with an exhaust and vacuum ON,
for safety reasons.

2.3.1 Solvent Preparation
3 g of purified collagen was dissolved in 7 ml of TFA (TriFloro Acetic acid) overnight
(42.85% of collagen by weight) [30]. The dissolved collagen solution was mixed
homogenously by a magnetic stirrer set at rate of 5 RPM for 15 minutes. 3 ml of final
prepared solution was filled in a 20 ml syringe and placed on the syringe pump.

2.3.2 Spinning Set-up
The syringe pump was set at a flow rate of 0.02ml/min. The needle (20 gauges) and metal
plate (23 cm X 23 cm) were placed 40 cm apart and an electric voltage of 20 KV was
applied across them. The humidity was lowered down to 10% ±2% during spinning. The
spinning was allowed to run for approximately 120-150 minutes ensuring the generation
of a thick, uniform mesh of randomly oriented fibers. The fibers were viewed under
scanning electron microscope (SEM) to ensure uniform fiber diameter, no phase
separation or presence of un-evaporated solvent.

2.3.3 Drying and Storage of Spun Mats
The spun mats were peeled off the metal plate using a metal blade and allowed to dry on
aluminum foil overnight in the fume hood at room temperature to ensure evaporation of
any residues of TFA from the mats. The dried mats were foiled and stored in desiccator
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for further use. To avoid sticking of mat on the metal plate, the plate can be covered with
aluminum foil prior to spinning.

2.4 Crosslinking of Electrospun Mats
The prepared collagen meshes were divided into six batches for 0.5% glutaraldehyde;
200mM EDC only; 200mM of EDC with 200mM of NHS; 1%, 5% and 10% of genipin.
The collagen mats were cut into square pieces of 1cm X 1cm dimension, with every batch
containing 16 pieces each, for free amino acid, SEM, DSC, TGA, dimensions and weight
measurements. Whole mat was crosslinked for mechanical testing separately. The
crosslinked samples were air dried in a chemical fume hood and stored in a desiccator.
2.4.1 Glutaraldehyde Crosslinking
In reference to protocols followed by Cheryl et al. study, the prepared samples were
vapor crosslinked using 0.5% of glutaraldehyde in DI water for 19 hours at room
temperature [17]. The crosslinking set-up was as shown in Figure 1.10. The crosslinked
meshes were further washed in distilled water to ensure removal of un-reacted aldehyde
residues.
2.4.2 Carbodiimide Crosslinking
The prepared collagen mats were liquid crosslinked with 200 mM of EDC only and 200
mM of EDC with 200 mM of NHS, following previously published protocols [18]. The
meshes were crosslinked in 200mM EDC only for 18 hours and 4 hours in 200mM of
EDC with 200mM of NHS dissolved in ethanol. After crosslinking the mats were washed
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with 0.1 M of sodium phosphate buffer for 2 hours to hydrolyze and remove any 0isoacylurea intermediate. The samples further rinsed with DI water and air dried [11].

2.4.3 Genipin Crosslinking
Three Genipin concentrations of 1%, 5% and 10% by weight dissolved in ethanol were
used to crosslink collagen mats for 72hours at 37°C [40]. The samples were later rinsed
in DI water and air dried. Change in color was evident of effective crosslinking [42].

2.5

Immersion Study

The crosslinked samples were first sterilized before starting the immersion study in
phosphate buffer solution (DPBS) for 3 months. The protocol followed for the
sterilization of samples was as follow:
Step 1: Soak in ethanol for 20 minutes.
Step 2: Pipette out the ethanol and add PBS. Soak for 4 minutes.
Step 3: Pipette out the PBS (step 2), add more PBS and soak for 25 minutes.
Step 4: Pipette put the PBS (step 3), add more PBS and soak for 20 minutes.
The samples were sealed in the petri dishes with parafilm and placed in the incubator
maintained at 37°C. The temperature was monitored regularly after an interval of every
hour for the first day and 1 week later, to ensure maintenance of stable temperature. The
samples were harvested after 1 month, 2 months and 3 months of incubation. Samples
were air dried under chemical fume hood and stored in desiccator.
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2.6 Morphological Studies
The samples were measured for length, width and weight before and after crosslinking
and after immersion for 1 month, 2 months and 3 months in PBS. The study was
performed on the hypothesis of detecting a noticeable difference in the dimension and
weight of the mats before and after crosslinking. More amino-acid bonds are formed
during crosslinking which would reduce the dimension of mats by bringing the collagen
fibers closer to one another while increasing the mass due to incorporation of
crosslinking reagent within and between the collagen molecules. The dimensions and
mass of collagen mat was assumed to reduce further after incubation in PBS relative to
duration of immersion due to degradation of collagen structure.

2.7 Porosity Measurements
The porosity of scaffold affects the cellular in-growth and matrix deposition.
Thus, it plays a critical role in determining the rate of tissue regeneration [20]. The
porosity was calculated before and after crosslinking and incubation study using
following formula as defined in [5]:
P = [ 1- { (Mass of fiber mat/ Volume of fiber mat) * 1/ Density of material}] * 100
Where, density of collagen was found to be 1.3 to 1.4g/cm [43].

2.8 Differential Scanning Calorimetric Measurements
The thermal properties of the electrospun mats can be quantified using thermo-analytical
methods. DSC determines the structural change in collagen fiber when subjected to cycle
of heat-cool-heat. It determines the thermal stability of the electro-spun mat. The
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denaturation temperature is analyzed by heating the sample under high-pressure in
aluminum pans and measuring the amount of heat required to raise the temperature of
material with respect to reference. The heat is either absorbed or released, depending on
nature of reaction if it is exothermic or endothermic, during phase transition. The
denaturation temperature is the point of onset for thermo-reversible un-winding of the
helical structure of collagen fibril. The hydrogen bonds break and there is a helix-to-coil
transition with increase in heat flow, resulting in formation of amorphous polymer known
as gelatin. As the temperature is lowered the coil tends to re-wind itself to restore the
original collagen helical structure (coil-to-helix transition). The helical structure is not
restored completely and contains segments of amorphous polymer phase. This provides
gelatin with elasticity and integrity. The glass transition temperature is the onset of
increased mobility within the material due to increase in temperature. A phase transition
is seen from amorphous to crystalline with change in heat capacity of the material.
The hypothesis of the study was to observe an increase in the glass transition
temperature after crosslinking of collagen mats. This could possibly occur as a result of
increase in crosslinking density which would require more heat to break the bonds and to
initiate or increase mobility within the material. The glass transition temperature can thus
be used to quantify the crosslinking density of collagen scaffold [19, 30]. The author also
hypotheses to observe a decrease in the glass transition temperature of collagen mats after
immersion in PBS as the incubation (37°C) would facilitate the degradation of the
collagen mats with time.
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The thermal analysis of collagen fiber was carried out with Q100 differential
scanning calorimeter; TA instruments New Castle, DE. The uncrosslinked collagen mat
was taken as control for the study. Approximately 5mg of sample was weighed and
hermetically sealed in aluminum DSC pans. The reference holder consisted of an empty
DSC pan, sealed and crimped. The heat-cool-heat cycle was selected to determine the
denaturation and glass transition temperature. The heating and cooling rate was
10°C/min. The denaturation of uncrosslinked collagen was found to be about 220°C to
230 °C from previous studies.

2.9 Thermal Gravimetric Analysis
The thermal gravimetric analysis was performed to detect the percent loss in weight with
increase in temperature of sample. The analysis was carried out on Q50
Thermogravimetric Analyzer and the results were analyzed using TGA-Q50 software.
Non-isothermal experiments were performed in temperature range of 0 to 250°C. The
samples were heated at 10°C with nitrogen flow rate of 50 cm 3 per min. The average
sample size was 3-4mg.
The collagen mat was cut into small pieces using scissors and weighed. An empty
pan was tare for reference. The heating rate was selected to be 10 °C/min over a range of
0 °C to 250 °C. The parameters were selected based on previous study on rat tail tendons.
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2.10 Determination of Free Amino-Acids
The percent of free amino-acid content of collagen mats was determined using 2,4,6trinitrobenzenesulphonic acid solution (TNBS-10% w/v in water), as a measure for
degree of crosslinking [12, 30]. Crosslinking increases the bonds between amino-acids
and thus reduce the free un-bonded amine groups. Hence the number of free amino-acid
was expected to decrease after crosslinking. The number would increase if the mat was
degraded and the bonds between amino groups were broken.
The sample of approximately 5 mg were incubated in an aqueous solution of
sodium carbonate, NaHCO3 (1 ml, 4% w/v) for 30 minutes. A solution of TNBS (1 ml,
0.5% w/v) was added in the same NaHCO3 solution and allowed to incubate at 40°C for 2
hours. 3mL of HCl (6M) was added to hydrolyze the samples at 60°C for 90 minutes.
The reaction mixture was diluted with 5 ml of DI water and absorbance was measured
using spectrophotometer at 420nm range. The blank was prepared following same
procedure, only the HCl was added prior to TNBS solution.

2.11 Mechanical Strength Measurements
The samples were tested on instron to determine the tensile strength and modulus of
crosslinked samples. The uncrosslinked collagen mat was taken as control. Five pieces
were tested for each batch after initial crosslinking (0 month), 1 month, 2 months and 3
months of immersion study. According to ASTM standard D3822-01, the minimum
gauge length to effectively test a specimen was found to be 10mm [44]. The mechanical
testing was carried out by undergraduate students as their project work. The samples were
cut in 10mm X 5mm dimensions. Paper strips were cut of uniform dimension with a
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window in the center for same dimensions as sample. This was to prevent the breaking of
sample while loading as they were very small. The sample was mounted on the paper
mold and loaded on the instron for testing. The extension was applied at 5mm/min with
sensitivity for failure set as 20% of maximum load. The samples were hydrated for 2-3
minutes in PBS prior to testing. The results were measured for maximum load and
Young's modulus.

CHAPTER 3
RESULTS AND DISCUSSION

3.1 Purification of Collagen

Figure 3.1 shows the purified type I collagen extracted from bovine tendons after
overnight drying at 45°C in oven. The bundled fibers were separated manually and stored
in desiccator to avoid degradation due to atmospheric moisture.

i

I

Figure 3.1 Purified type-I collagen.

3.2 Electrospinning of Purified Collagen

The electro-spun collagen mats were viewed under scanning electron microscope to
ensure uniform fiber diameter, no phase separation and no presence of any un-evaporated
\

1

solvent within or on the fibers. The fibers appeared to be uniform in diameter without any
\

phase separation [Figure 3.2]. -There was no un-evaporated solvent seen' within or over
the fibers. The presence o~ beads might' ~ffect the cellular' response and cell-tissue
regeneration and were thus avoided. The fiber diameter was measured to be
approximately 2.50J-lm.
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Figure 3.2 SEM image of an electro spun, un-crosslinked collagen scaffold.

3.3 Crosslinking of Electro-spun Collagen Fiber Scaffold
The crosslinking of the electro spun collagen mat with different crosslinkers produced
different physical and morphological changes. The genipin crosslinked samples turned
greenish-blue in color and shrunk. The EDC and EDC with NHS · crosslinked samples
I

I

stayed colorless and did not change in size noticeably. The

glutar~ldehyde

crosslinked

samples turned pale yellow in color, sticky and gelled [See Appendix C for the pictures].

3.4 Immersion Study
The glutaraldehyde and genipin 1% crosslinked

sam~~es

started to gel after the

sterilization process and were completely dissolved following 1 mqnth of immersion in
the phosphate buffered saline (PBS) at 37°C. The genipin 5% crosslinked samples started

.

~.

.. ... ;

to disintegrate after 2 moriths of incubation and were very difficult to harvest from the
solution [Appendix. C].
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The genipin 5% and genipin 10% samples released color during incubation and
turned the PBS dark bluish green in color. Genipin 10% samples could be extracted from
solution without difficulty at the end of immersion study.
The EDC only and EDC with NHS crosslinked samples did not change color and
maintained structural integrity throughout 3 months of incubation without noticeable
shrinkage. EDC and EDC with NHS crosslinked samples were soft, but easy to handle
than genipin crosslinked mats. There was no disintegration in EDC and EDC with NHS
crosslinked mats after 3 months of incubation.

3.5 Dimensions and Weight Measurements
For all the crosslinkers the starting sample size was 1 cm X 1 cm. At each time point,
four pieces were harvested and measured for dimensions and weight, of all the
concentration and crosslinkers. The average of all the values was taken to compare
between different samples (n=4).
The uncrosslinked samples dissolved instantaneously in PBS. The overall
dimensions decreased and weight increased after crosslinking. The dimensions of
glutaraldehyde and genipin 5% crosslinked samples reduced the greatest as compared to
uncrosslinked, genipin 1%, genipin 10%, EDC and EDC with NHS crosslinked samples
[Figure 3.3.a]. The dimension of genipin 1% crosslinked samples was found to be greater
than genipin 5% and comparable to genipin 10% crosslinked samples. The SEM images
of genipin 1% sample shows that the fibers swelled a lot after crosslinking and this might
be one of the reasons for not a noticeable decrease in dimension of genipin 1%
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crosslinked sample. The dimensions were reduced as compared to uncrosslinked mat
[Figure 3.3.a].
The reduction in dimensions of EDC with NHS crosslinked samples was not
significantly different from the uncrosslinked collagen mat. The crosslinked samples did
not shrunk much in dimensions but there was an increase in weight after crosslinking as
compared to uncrosslinked samples. The dimensions of the EDC with NHS crosslinked
samples were greater than genipin 1%, 5%, 10% and EDC crosslinked samples [Figure
3.3.a]. The EDC crosslinked samples shrunk greater than genipin 10% and EDC with
NHS crosslinked samples in dimensions [Figure 3.3.a].

Figure 3.3 Dimensions for all the crosslinked samples at 0 month (a. top) and 1 month
(b. bottom) of incubation.
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The dimensions of genipin 10% crosslinked samples reduced greatly as compared
to starting of incubation study and were comparable in size to genipin 5% after 1 month
of incubation [Figure 3.3.b]. There was a decrease in the dimensions of EDC and EDC
with NHS crosslinked samples as compared to those before incubation, but they were
greater in dimensions than genipin 5% and genipin 10% crosslinked mat [Figure 3.3. b].
The glutaraldehyde and genipin 1% crosslinked samples dissolved after 1 month of
incubation [Figure 3.3.b].

Figure 3.4 Dimensions for all the crosslinked samples after 2 months (a) and 3 months
(b) of incubation.
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The dimensions of genipin 5% reduced greatly following 2 months and 3 months
of incubation [Figure A.1.3a]. It reduced the greatest among all crosslinkers
[Figure.3.4.b]. The dimensions of genipin 10%reduced gradually with incubation [Figure
A.1.4a] but was very similar to dimensions of EDC crosslinked mat after 3 months
[Figure 3.4.b]. The dimensions of EDC with NHS crosslinked mat were comparably
greater than the dimensions of rest of the crosslinkers [Figure 3.4.b].

Figure 3.5 Weights for all the crosslinked samples at 0 month (a) and 1 month (b) of
incubation.
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The increase in weight after crosslinking was found to be highest for genipin 10%
concentration [Figure 3.5a]. The weight of EDC crosslinked mat increased greater than
genipin crosslinked samples which shows that the water uptake for EDC crosslinked mat
was greater. Genipin might be crosslinking collagen mat more efficiently than EDC.
Similarly the percent increase in weight of EDC with NHS crosslinked samples was
lesser with incubation and among all the crosslinker, showing NHS improved the
crosslinking efficiency of EDC, thus reducing the water uptake.

Figure 3.6 Weights for crosslinked samples at 2 month (a) and 3 month (b) of incubation.
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The weights of genipin 5% [Figure A.1.3b] and EDC with NHS [Figure A.1.6b]
crosslinked gradually decreased with increase in incubation time. Weight of genipin 5%
decreased most among all crosslinkers [Figure3.6b]. Genipin 10% and EDC crosslinked
samples showed a similar behavior as genipin 5%, the percent reduction in weight for 2 nd
and 3 rd month of study was not significantly different from each other. It reduced more
than the EDC crosslinked mats. The weight for EDC was greater than EDC with NHS
crosslinked mat, suggesting that the EDC with NHS crosslinked mat was degrading faster
than the EDC only crosslinked mat during incubation.
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3.6 Free Amino-Acid Measurements
The free amino-acid count was used to determine the crosslinking extent of crosslinked
samples. N=5 for each crosslinker and for every time point (150pl).

Table 3.1 Free Amino-Acid Count for all the Crosslinkers

Sample

Weight

Control 1

(g)
0.0000

Control 2
Uncrosslinked
GI utaraldehyde
Genipin 1%- 0 month
Genipin 5%- 0month
Genipin 10%- 0month
EDC- 0 month
EDC with NHS- 0 month
Genipin 5%- lmonth
Genipin 10%- lmonth
EDC- 1 month
EDC with NHS- 1 month
Genipin 5%- 2 months
Genipin 10%- 2 months
EDC- 2months
EDC with NHS- 2 months
Genipin 5%- 3 months
Genipin 10%- 3 months
EDC- 3 months
EDC with NHS- 3 months

0.0000
0.0024
0.0024
0.0024
0.0024
0.0024
0.0025
0.0024
0.0024
0.0024
0.0026
0.0026
0.0026
0.0024
0.0026
0.0026
0.0025
0.0026
0.0026
0.0026

Absorbance
Al
A2
0.000
-0.001

A3
0.003

A4
0.002

A5
-0.002

0.006
0.403
0.563
0.361
0.323
0.311
0.030
0.205
0.173
0.178
0.105
0.006
0.143
0.113
0.131
0.095
0.339
0.289
0.162
0.105

0.001
0.420
0.636
0.360
0.337
0.342
0.027
0.203
0.187
0.201
0.100
0.068
0.153
0.125
0.138
0.103
0.361
0.299
0.193
0.096

0.002
0.412
0.587
0.331
0.353
0.322
0.026
0.214
0.200
0.208
0.093
0.075
0.148
0.129
0.144
0.107
0.344
0.303
0.206
0.095

-0.003
0.436
0.597
0.370
0.330
0.353
0.028
0.212

-0.003
0.434
0.537
0.331
0.318
0.321
0.029
0.202
0.186
0.199
0.099
0.059
0.157
0.128
0.138
0.105
0.353
0.299
0.173
0.095

0.180
0.211
0.099
0.088
0.158
0.129
0.139
0.097
0.357
0.295
0.201
0.101

Average
Absorbance

Standard
Deviation

0.000

0.00

0.000
0.419
0.579
0.351
0.326
0.325
0.029
0.203
0.182
0.193
0.101
0.044
0.151
0.122
0.136
0.101
0.351
0.296
0.176
0.099

0.00
0.01
0.04
0.02
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.03
0.01
0.01
0.01
0.01
0.01
0.01
0.02
0.00

For the 0 month of incubation, immediately after crosslinking, the free amino
group count of EDC was lowest as compared to all other crosslinkers, suggesting EDC
crosslinked the mat to the greatest extent [Figure 3.7]. The free amino count for the
genipin 1%, 5% and 10% crosslinked samples immediately after crosslinking was not
significantly different. It was greater than EDC and EDC with NHS crosslinked samples
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[Figure 3.7]. There was no significant difference seen in the count for genipin 5% and
10% after 1 month of incubation [Figure 3.8].

Figure 3.7 Free amino-acid count for all crosslinked samples before incubation.
The EDC with NHS crosslinked samples had lower free amino group count than
genipin crosslinked samples but higher than the EDC crosslinked samples [Figure 3.8].
After 1 month of incubation, the free amino acid group for EDC was lower than the
genipin 5% and 10% concentration, suggesting the genipin crosslinked mat degraded
faster than EDC and EDC with NHS crosslinked mats [Figure 3.8].

Figure 3.8 Free amino-acid count for all crosslinked samples after 1 month of incubation.
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The count for EDC with NHS was found to be lower than EDC suggesting the
degradation of EDC with NHS crosslinked mat was slower than the EDC crosslinked
mat. This was supported by the observation that the dimension for EDC with NHS
crosslinked samples was greater than EDC samples after 1 month of incubation [Figure
3.8]. Following 2 months of incubation, the free amino acid count for EDC was higher
than the EDC with NHS crosslinked samples and was comparable to the genipin 5% and
10% concentrations [Figure 3.9].
The free amino acid count for genipin 10% was lesser than the genipin 5%
crosslinked samples after 2 months of incubation. The finding can be supported with the
observation that the greatest decrease in dimensions and weight was seen for genipin 5%
crosslinked samples than rest of the crosslinker after 2 months of incubation [Figure 3.9].

Figure 3.9 Free amino-acid count for all crosslinked samples after 2 months of
incubation.

The count for EDC was comparable to the genipin 5% crosslinked sample after 2
months of incubation [Figure 3.9]. The free amino count greatly increased after 3 months
of incubation as compared to 1 month and 2 months of data. The highest count was found
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for genipin 5% which was very closer to the control value, suggesting the mat completely
degrade following 3 months of incubation [Figure 3.10].

Figure 3.10 Free amino-acid counts for all crosslinkers after 3 months of incubation.
The free amino-acid count for EDC with NHS crosslinked samples was found to
lower than the genipin 10% crosslinked samples after 3 months of incubation but was
greater than the EDC with NHS crosslinked samples, suggesting the EDC with NHS
crosslinked samples were more resistant to degradation than any of the other crosslinkers
[Figure 3.10].
The free amino acid count was lower for all the crosslinkers as compared to the
uncrosslinked sample, suggesting all the reagents effectively crosslinked the mat except
glutaraldehyde for which the count was found higher than the control. This could be due
to denaturation of fibrous mat during crosslinking as glutaraldehyde was mixed with
water to vapor crosslink the samples and moisture degrades collagen. The free amino acid
groups genipin 5% crosslinked samples decreased for the first two months of incubation.
The count was increased greatly for third month of incubation. The decrease in free
amino acid count indicates continued crosslinking [Figure A.1.2.1].
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A similar pattern was observed for genipin 10% crosslinked samples too. During
incubation, the PBS for genipin 5% and 10% turned blue in color, suggesting that even
after washes and sterilization of samples prior to incubation, there was some crosslinker
left unwashed which was released when immersed in PBS. As genipin crosslinking was
done initially at 37°C, the incubation conditions favored additional crosslinking of the
mat, which was evident from the lesser free amino acid count and further reduction in
dimensions of the mat with incubation. The mat slowly started to degrade after 2 months
of incubation seen by an increase in the free amino groups which suggests lesser
availability of crosslinking molecules in the solution. The increase in free amino-acid
count for genipin 5% and genipin 10% was the indication for start of degradation of
crosslinked mat [Figure A.1.2.2]
The free amino groups for EDC crosslinked samples was very less for the 0
month of incubation (just after crosslinking), suggesting EDC effectively crosslinked the
collagen mat structure. The free amino group count increased, with increase of incubation
time suggesting the mat degraded slowly with time [Figure A.1.2.3].
The free amino groups was lower than the uncrosslinked samples showing EDC
with NHS effectively crosslinked the collagen mat. The count decreased after the first
month of incubation and than increased steadily the following 2 months and 3 months of
incubation in PBS [Figure A.1.2.4].
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3.7 SEM Measurements

The SEM images were taken using Leo 1350 VP. The images were analyzed to detect the
presence of fibers, study the morphology of fiber (uniformity, diameter) and scaffold, to
measure the change in diameter of fiber before and after crosslinking and following
incubation. The fiber diameter was analyzed using imageJ software. The average fiber
diameter of uncrosslinked electro spun type I collagen fibrous mat was found to be
approximately 2.50Jlm.

I

/

Figure 3.11 SEM image of uncross linked, electrospun collagen fiber mat.

No fibers were seen for the glutaraldehyde crosslinked samples. The fibers were
fused together, gelled to form a film-like structure

[Figun~

3.l2a].

The fibers were

swelled for genipin 1%, genipin 5% and genipin 10% crosslinked :r;nat [Figure 3.12b,
3.l2c, 3.12d]. With the EDC and EDC

wit~

NHS crosslinked samples, the fibers were

easily distinguishable and pores appeared between the fibers [Figure 3.12e, 3.12±].
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(a)

(b)

(c)

(d) ,

~
.~
00
Figure 3.12 SEM images for glutaraldehyde (a), genipin 1% '(0), genipin 5% (c), genipin
10% (d), EDC 200mM (e) and EDC with NHS 200 mM each (f) crosslinked samples
prior to incubation.

* SEM images for all the crosslinkers at every time point is available in Appendix A.3.
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After measurement of fiber diameter using imageJ software, the fiber diameter of
each crosslinked mat was compared to fiber diameter of its specific control mat to
calculate the percent change in fiber diameter before and after crosslinking and at three
different time points of incubation study. The results (n=1) can be summarized as follow:

Figure 3.13 The percent change in fiber diameter as compared to their control mats after

crosslinking (0 month). Note: The magenta color shows a negative value.

The percent fiber diameter change for genipin 1% crosslinked sample was
increased by 136.61 from 2.541.1m (control) to 6.01 lam [Table A.3.3 b].The fiber
diameter for genipin 5% crosslinked samples increased from 2.75μm (control) to 4.28 VIM
having a percent increase in fiber diameter by 55.63% [Table 3.4 b]. The diameter for
genipin 10% decreased after crosslinking from 2.75 μm to 2.45 having a negative
value for change in diameter of -10.90% [Table 3.5 d]. The fiber diameter for EDC
increased from 2.14 lam to 2.58 with 20.44% increase in the fiber diameter [Table 3.6.e].

* All the measurements for fiber diameter of crosslinked sample, control and percent
change in fiber diameter is available in Appendix A.3.
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Similarly, diameter for EDC with NHS crosslinked fibers increased from 2.39 Il m
to 3.99 Ilm, having 66.94% increase in diameter value [Table 3.7.e]. Genipin 1%
crosslinked fibers swelled the greatest among all the crosslinkers followed by EDC with
NHS. EDC swelled the least while genipin 10% crosslinked fibers shrunk the greatest
among all crosslinked samples [Figure 3.13].
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Figure 3.14 The percent change in fiber diameter as compared to their control mats after
1 month incubation in PBS.

Genipin 5% crosslinked samples had the highest percent increase in fiber
diameter after 1 month of incubation. The fibers swelled in dimensions too [Figure 3.14].
The fiber diameter for genipin 10% increased (positive value) [Figure 3.14]. The EDC
crosslinked fibers swelled greater than the EDC with NHS crosslinked samples. NHS
improved the crosslinking efficiency of EDC, thus reducing the water uptake [Figure
3.14]. The percent increase in diameter after 1 month of incubation was least for genipin
10%, and highest by genipin 5%. The difference in water uptake might be a factor of
difference in crosslinking extent due to higher concentration of crosslinker.
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Figure 3.15 The percent change in fiber diameter as compared to their control mats after
2 months incubation. Note: The magenta color shows a negative value.

The fiber geometry of genipin 5% crosslinked mat collapsed after 2 months of
incubation and no fibers were visible. The genipin 10% swelled sharply as compared to 1
month of incubation. The values for EDC crosslinked sample also increased after 2
months of incubation whereas the EDC with NHS crosslinked fibers started to shrink
with time [Figure 3.15]. The decrease in fiber geometry shows degradation of the
crosslinked mat during immersion in PBS at body temperature over time.
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Figure 3.16 The percent change in fiber diameter as compared to their control mats after
3 months of incubation. Note: The magenta color shows a negative value.

Following 3 rd month of incubation in PBS, the fiber diameter for genipin 10%
continued to increase. The EDC and EDC with NHS crosslinked samples fiber diameter
decreased with incubation time [Figure 3.16]. The EDC with NHS crosslinked fibers
shrunk more than the EDC crosslinked fibers. The EDC with NHS crosslinked mat
degraded faster than EDC crosslinked mat.
On summarizing all the results, the overall fiber diameter of genipin 5%
crosslinked samples increase for the first month of incubation and then continued to swell
until gelled out to form film like structure. EDC crosslinked fibers swelled for the first 2
months of incubation and then started to shrink. EDC with NHS crosslinked samples
swelled only for the first month of incubation and than gradually decreased. The fiber
diameter in genipin decreased with increase in concentration of crosslinker, as more
bonds would have formed causing greater crosslinking within the collagen structure.
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3.8 Porosity Measurements
The porosity was calculated for all the crosslinked samples using:
P = [ 1- { (Mass of fiber mat/ Volume of fiber mat) * 1/ Density of material}] * 100
Where, density of collagen was found to be 1.3 to 1.4g/cm [4]. Resulted are listed in
Table 3.1. All the samples were cut with blade to equal dimensions before measurement.

Table 3.2 Porosity for Uncrosslinked and Crosslinked Mats (n=1).
Avg
length

weight

Porosity

Control
porosity

%
decrease

2.63

2.60

5.5

75.94

99.72

23.85

8.79

8.14

8.55

6.8

99.16

99.99

0.83

2.79

2.55

2.95

2.73

3.2

87.40

99.55

12.20

2.37

2.52

2.23

2.59

2.43

0.8

95.69

99.55

3.87

G5-2

2.80

2.73

2.72

2.70

2.74

2.6

90.25

99.55

9.34

G5-3

2.78

3.51

2.98

3.48

3.19

5.0

88.12

99.55

11.48

G10-0

5.38

5.42

5.34

4.91

5.26

6.0

96.83

99.50

2.68

G-10-1

3.62

3.35

3.61

3.56

3.54

2.3

95.99

99.50

3.52

G10-2

5.28

4.68

5.26

4.25

4.87

5.7

96.14

99.50

3.37

G10-3

5.62

5.19

5.91

5.77

5.62

7.8

96.62

99.50

2.89

E-0

5.66

5.40

5.83

5.55

5.61

3.2

98.60

99.31

0.71

E-1

5.83

5.21

5.69

5.11

5.46

2.9

98.62

99.31

0.69

E-2

5.50

6.36

6.02

5.38

5.82

7.1

97.22

99.31

2.10

E-3

6.41

5.80

6.22

5.98

6.10

4.7

98.40

99.31

0.91

EN-0

9.26

8.88

9.25

8.94

9.08

3.8

99.60

99.65

0.05

EN-1

4.08

3.67

4.03

3.29

3.77

3.2

95.39

99.65

4.27

EN-2

6.22

6.28

6.03

6.08

6.15

3.9

98.71

99.65

0.94

EN-3

4.58

5.16

4.52

4.99

4.81

0.8

99.44

99.65

0.21

Samples

Dimensions

Glutaraldehyde

2.78

2.85

2.14

G1

8.69

8.57

G5-0

2.61

G5-1
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The measured weight was in milligrams and dimensions in millimeters.
On plotting the results for decrease in porosity after crosslinking before incubation:

Figure 3.17 The percent decrease in the porosity of samples as compared to control after

crosslinking and before incubation. Note: The values are negative in number.

The glutaraldehyde crosslinked samples porosity decreased by 23.85%, indicative
of crosslinking, reduction in porous volume as the fibers were drawn closer [Figure
3.17]. The percent decrease in porosity for genipin 1% crosslinked samples was found to
be very small (-0.83%), lesser than genipin 10% and comparable to EDC.
Genipin 5% porosity decreased by 12% approximately, after crosslinking and
increased following incubation for first month of incubation. The decrease in porosity
might be caused due to swelling of fibers or additional crosslinking [Figure 3.17]. The
SEM images supported the first phenomena of increase in fiber diameter [Table A.3.4b]
after crosslinking.
Genipin 10% the porosity decreased after crosslinking but was lesser than genipin
5% and glutaraldehyde crosslinked samples possibly caused due to shrinkage of fiber
[Table A.3.5a] as also shown in SEM images [Figure 3.17]. However even after 1 months
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of incubation the porosity continued to decrease, evident of additional crosslinking during
incubation [Figure 3.18]. It started to increase after 2 months of incubation [Figure 3.19a]
probably due to exhaustion of crosslinker in the solution, and the mat started to degrade
[Figure 3.19b].
Similar phenomena were observed for genipin 5% crosslinked mats after 1 month
of incubation [Figure 3.18]. Porosity increased from second month, suggesting there
might not be enough crosslinker after 1 month to cause more crosslinking and shrinkage
of mat. Thus, the mat starts to degrade after 1 st month of incubation. The decrease in
porosity of EDC and EDC with NHS crosslinked mat was not as high as other
crosslinkers [Figure 3.17], suggesting lesser shrinkage of the mat after crosslinking but
with increase in weight as noticed in dimensions and weight measurements [Table A.1.5
and A.1.6].

Key notes:
v Porosity might decrease either due to shrinkage of mat or swelling of fibers.
v Porosity increases as a result of shrinkage of fibers or degradation of mat.

Plotting of results for 1 month of incubation showed that:

Figure 3.18 The percent decrease in the porosity of samples as compared to their control
after 1 month of incubation. Note: The values are negative in number.
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The porosity for genipin 5%, genipin 10% and EDC with NHS decreased greatly
after 1 month of incubation [Figure 3.18] caused either due to shrinkage of mat as a result
of crosslinking for genipin 10% [Figure 3.14] or due to increase in fiber diameter, for
EDC with NHS [Figure 3.14].
The decrease in porosity was least for EDC crosslinked samples [Figure 3.18].
The porosity was decreased as compared to that prior to incubation [Figure3.17],
suggesting EDC crosslinked fibers swelled during first month of incubation [Figure
3.14] .

Figure 3.19 The percent decrease in the porosity of samples as compared to their control
after crosslinking and incubation for 2 months (top), 3 months (bottom). Note: The values
are negative in number.
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The porosity of genipin 5% crosslinked samples decreased greatly following 2
months and 3 months of incubation [Figure 3.19a, 3.19b], indicating greater shrinkage of
mat, also shown by SEM [Table 3.4a, 3.4b], that the fibers continued to swell collapsing
the fiber architecture after 2 nd month of incubation and the dimensions decreased greatly
showing faster degradation of mat [Figure 3.3a to 3.4b].
The porosity for genipin 10% decreased for first 2 months [Figure 3.17, 3.19a]
and than started to increase during 3 rd month of incubation [Figure 3.19b], possibly
caused due to crosslinking of mat for the first 2 months and than the mat started to
degrade following third month of incubation. Porosity increased for EDC and EDC with
NHS crosslinked mats [Figure 3.19a, 3.19b] indicating the degradation of mat following
incubation.
On summarizing all the results for porosity the genipin 5% mat continued to
crosslink for the first month of incubation and than started to degrade while genipin 10%
mats continued to crosslink for 2 months before starting to degrade supported by the
SEM and dimensions and weight measurement results too.
No such behavior was observed for EDC and EDC with NHS crosslinked
samples, they did not continue to crosslink during incubation instead started to degrade
following first month of incubation. The decrease in porosity for the first month of
incubation could be contributed to swelling of fiber after immersion in PBS, shown in
SEM images too.
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3.9 TGA Analysis
The Thermal Gravimetric Analysis was performed to study the percent weight loss with
increase in temperature of the samples. TGA was done for uncrosslinked collagen mat,
collagen mat held over water for 19 hours and for EDC crosslinked mat, to see the effect
of moisture and cro s slinking.

Figure 3.20 TGA plot for uncrosslinked collagen mat. The mat was stored in dessicator
to prevent absorption of moisture.
The loss of water was seen over a temperature range of 47°C to 110 °C [Figure
3.20, 3.21]. The loss of moisture was more prominent for collagen mat held over water
for 19 hours, separated by a poly mesh film.
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Figure 3.21 TGA plot for collagen mat held over water for 19 hours.

Figure 3.22 TGA plot for EDC crosslinked collagen mat without incubation.
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The moisture can accelerate the degradation of collagen, possibly the reason for
early dissolution of glutaraldehyde crosslinked mat as similar protocol was followed
during crosslinking. The TGA for crosslinked collagen mat showed retention of water for
a longer duration as compared to uncrosslinked mat [Figures 3.21, 3.22], which is evident
for crosslinking of the structure.

Figure 3.23 TGA plots for uncrosslinked mat (solid line) and EDC crosslinked mat
(dashed line).

There was also noticeable change found in the pattern of weight loss for the EDC
crosslinked samples as compared to the uncrosslinked mat [Figure 3.23]. All the results
from TGA plots were used to better analyze the DSC data.
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3.10 DSC Measurements
The Differential Scanning Calorimetric measurement was performed to analyze the
thermal behavior of collagen scaffolds by studying their denaturation and glass transition
temperature peaks. The denaturation temperature is the unwinding of the triple helical
structure of native collagen by breaking of the native bonds which stabilizes the structure.
The glass transition temperature is the point where the mobility of particles increases
within the structure gained by the thermal heating, and the material change from solid
rigid phase to a plastic, rubbery phase.
A denaturation temperature is seen for native collagen while glass transition
temperature is seen for denatured collagen, gelatin. Collagen or pure protein does not
have a glass transition temperature. The native collagen does not dissolve in water
because the bonds present in the native triple helical structure stabilizes the structure,
whereas, it is seen that electrospun collagen fibers dissolve instantaneously in aqueous
medium, which necessitates the physical and chemical treatment of these structures to
improve their stability. The curiosity to understand the reason for dissolution of
electrospun mat in water over native collagen, while both are same material, lead to
design of new method by the author. The DSC was ran for electrospun collagen fiber
without crosslinking, up to 150°C and held at this temperature for 3 minutes to evaporate
all the moisture. The temperature was lowered down to 0 °C and ramped up to 250 °C at a
heating rate of 10 °C/min. The DSC plot obtained is shown in Figure 3.24.
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Figure 3.24 DSC plot for the electrospun collagen mat without crosslinking.

The DSC plot showed both a glass transition temperature at 153.09 °C and a
denaturation temperature at 232 °C which showed that the electrospun collagen mat
consisted of both native and denatured collagen. The native collagen has to be dispersed
in the gel structure, as the mat dissolves in water, which showed that the native collagen
are not assembled together to hold the structure together and prevent dissolution, as
occurs for non electrospun pure collagen.
Thus, electrospinning of collagen reassembles the collagen fibrils together in fiber
structure. There is not bonding present between the helical structure and the native
collagen is dispersed within denatured collagen structure which causes the elctrospun mat
to dissolve in water as the gel swells and disintegrate.
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DSC was ran for all the samples with heat-cool-heat cycle from 0 °C to 250 °C at
10 °C heating and cooling rate. Controls were prepared for all the crosslinker by treating
them similar to crosslinked samples without addition of crosslinker.
v Glutaraldehyde control: mat was held over water for 19 hours separated by poly
mesh.
v Genipin control: mat was immersed in ethanol and incubated for 3 days at 37 °C.
v EDC control: mat was immersed in ethanol for 18 hours at room temperature.
v EDC with NHS control: mat was immersed in ethanol for 4 hours at room
temperature.

Table 3.3 Tg and Td for Uncrosslinked Collagen Mat, Control and Crosslinked Mat
Before and After Incubation
Samples

Uncrosslinked
Glutaraldehyde control
Glutaraldehyde
Genipin control
Genipin 1%- 0 month
Genipin 5%- 0month
Genipin 5%- 1month
Genipin 5%- 2 months
Genipin 5%- 3 months
Genipin 10%- 0month
Genipin 10%- 1month
Genipin 10%- 2 months
Genipin 10%- 3 months
EDC control
EDC- 0 month
EDC- 1 month
EDC- 2months
EDC- 3 months
EDC with NHS control
EDC with NHS- 0 month
EDC with NHS- 1 month
EDC with NHS- 2 months
EDC with NHS- 3 months

Glass Transition
Temperature (Tg)

Denaturation
Temperature (Td)

165.83

238.11

178.19
183.57
186.88
194.00
200.27
210.99
203.25
206.90
208.62
203.35
208.13
210.05
182.55
173.63
187.27
182.18
184.57
184.19
158.83
181.70
189.95
191.18

231.33
230.71
230.41
230.71
234.41
235.03
*
*
*
*
*
*
230.71
228.86
200.81
*
207.90
228.56
231.83
*
201.12
203.89

* The denaturation temperature was not clearly seen. All the DSC graphs are shown in
Appendix B.
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The DSC data showed that the denaturation of native collagen was about 230°C.
The denaturation temperature was not seen for some of the crosslinked samples and was
not taken as an indictor to determine crosslinking extent, instead the glass transition
temperature was considered. The glass transition temperature shifts up with increase in
crosslinking density and vice versa.
The Tg of control increased after crosslinking for glutaraldehyde and genipin
crosslinked samples, indicative of effective crosslinking. For EDC and EDC with NHS
crosslinked mat the Tg lowered down. The Tg for genipin crosslinked samples increased
with increase in concentration for crosslinking.
Tg of genipin crosslinked samples was found to be greater than glutaraldehyde
treated mats, showing genipin can crosslink collagen mat more effectively than
glutaraldehyde. The glutaraldehyde treated mats were not effectively crosslinked and thus
continued to uptake water, swell, until dissolved.
Genipin 1% and 5% were able to crosslink the collagen mat, seen by increase in
Tg, but the crosslinking density was not enough to resist the swelling of fibers due to
water uptake and thus the mat eventually dissolved after 1 month and 2 months of
incubation.
Tg for genipin 10% crosslinked mat decreased during first month of incubation,
probably due to degradation of mat. The author hypothesis that during incubation the
degrading mat released un-reacted crosslinker in PBS which turned the color of solution
blue. This crosslinker continued to crosslink the collagen mat additionally as the
temperature favored the mechanism too. This hypothesis was proven by an increase in Tg
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seen with increase in incubation time. Thus, genipin 10% crosslinked mat continued to
crosslink even during incubation.
The Tg for EDC and EDC with NHS was found to be lower than its control. This
could possibly due to chemical nature of the compound. A dual peak was seen in EDC
crosslinked mat without incubation, before the denaturation of collagen [Figure 3.25].
This could be due to early breaking of the crosslinker molecule before denaturation of
collagen. The EDC might not be as thermally stable as genipin and glutaraldehyde. These
are chemical reagents and they might react under the testing conditions for DSC which
may affect the results.

Figure 3.25 DSC plot for EDC crosslinked mat. Dual peaks are seen before the
denaturation of collagen which might be breaking down of crosslinker molecule.
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Figure 3.26 DSC plot for EDC control.

Figure 3.27 DSC plot for EDC with NHS control.
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Another effect to be considered was the environment the samples were subjected
to during incubation. The control was immersed in ethanol while the incubation was
performed in PBS. The degradation was taking place in water media and water have
found to plasticize the Tg lowering the denaturation temperature.
The distortions seen in the EDC and EDC with NHS control mat DSC plots were
not clear and could possibly be due to vaporization or decomposition of ethanol [Figures
3.26, 3.27]. These behaviors might also affect the breakdown of EDC or release of
crosslinker molecule which may lower the Tg. These are chemically reactive agents and
they might be reacting at high temperature.
Additionally, variation in the crosslinking extent could contribute to variation in
values to Tg than expected. Collagen mats were immersed in ethanol, crosslinker solution
but depending on the variation for diffusion of crosslinker within the scaffold matrix
would affect the crosslinking degree. This would in turn depend on the uniformity and
thickness of the electrospun mats. These distortions in DSC plots were not seen for
genipin control [Figure B.3]. They were also treated differently (3 days incubation, body
temperature). These treatments might affect the thermal behavior of material all together.

CHAPTER 4
CONCLUSION
The vapor and liquid crosslinking mechanism followed in this project can be used to
effectively crosslink electrospun collagen mat. The author developed a new method to
successfully crosslink electrospun collagen fibers with genipin. The author also explained
the possible reason for dissolution of electrospun collagen in water, which necessitates
the need for crosslinking of collagen scaffold.
On comparing all the crosslinkers and different concentration used in the current
study, it can be concluded that genipin is an effective crosslinker. It was found to be more
thermally stable than EDC and does not break down at higher temperature. Following
incubation for 3 months at body temperature gave a better understanding of possible
behavior of crosslinked mats in-vivo. The EDC had the lowest free amino acid count after
crosslinking and the number continued to be lower than rest of the crosslinker, after
incubation also, which showed that EDC can effectively crosslink collagen mats. NHS
showed to enhance the crosslinking efficiency of EDC but not significantly. EDC and
EDC with NHS treated scaffolds were able to maintain fiber architecture till end of study
(3 months in PBS) while other crosslinked mats either dissolved or disintegrated except
for genipin 10% for which fibers were detected clearly. The fiber diameter, dimensions,
free amino acid count decreased with increase in genipin concentration while Tg
increased with increase in crosslinker concentration. The authors goal to effectively
crosslink electrospun type I collagen scaffold and to maintain the structure in PBS during
incubation, was successfully achieved and fulfilled. The choice of crosslinker would
depend on its application and cellular response to crosslinked mat.
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CHAPTER 5
FUTURE WORK
In this project my endeavor was to create scaffolds with uniform fiber diameter and
improve their physical and chemical properties by chemical treatment while considering
the physiochemical effects of cytotoxicity and inflammation in account. Future work can
include generating fibers in nanometer range as previous studies have shown that nanofibers can mimic the ECM more closely.
An in-vitro cell study would definitely give a better insight to possible tissue
regeneration mechanism when using one of the different crosslinkers used in the current
study. This would provide a better understanding of the cellular response to the
crosslinked scaffold which were compared only on the physio-chemical basis in the
current study.
New method can be developed to generate crosslinked electrospun fibers. Genipin
can be dissolved in common solvent for collagen, for instance, HFIP with ethanol can be
used to dissolve genipin and collagen and than electrospin the solution to generate
crosslinked scaffold. Method optimization might be needed to ensure the solution is not
completely crosslinked before spinning but is crosslinked enough, as genipin is a slow
crosslinker and require body temperature to crosslink. This study would give a biological
viability to further characterize and generate more effective scaffolds for tissue
engineering application.
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APPENDIX A
DIMENSIONS, WEIGHT, FREE AA MEASUREMENTS AND SEM IMAGES

A.1 Dimensions and Weights
The dimensions for all the samples was calculated after crosslinking and 1 month, 2
months and 3 months of incubation in PBS at body temperature. For all the
measurements, n=4 at each time point and for every crosslinker. All the dimensions are in
centimeter and weight is in grams.

Figure A.1.1 Weight and dimension for glutaraldehyde crosslinked and control.
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Table A.1.1 Dimensions and Weights for Glutaraldehyde Crosslinked Mat

Batch #1
Before
crosslinking

After
crosslinking
( Omonth)

Batch #2
Before
crosslinking

after
crosslinking

Batch #3
Before
crosslinking

after
crosslinking

Batch #4
Before
crosslinking
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Table A.1.2 Dimensions and Weights for Genipin 1% Crosslinked Mat

Batch #1
Before
crosslinking

After
crosslinking
( Omonth)

Batch #2
Before
crosslinking

after
crosslinking

Batch #3
Before
crosslinking

after
crosslinking

Batch #4
Before
crosslinking

after
crosslinking
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Figure A.1.2 Dimension and weight for genipin 1% crosslinked and uncrosslinked mat.

Figure A.1.3 Dimension and weight for genipin 5% crosslinked mat compared to control.
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Table A.1.3 Dimensions and Weights for Genipin 5% Crosslinked Mat

Batch #1
Before
crosslinking
After
crosslinking
( Omonth)

Batch #2
Before
crosslinking
after
crosslinking

After
1 month
immersion

Batch #3
Before
crosslinking
after
crosslinking

After
2 month
immersion

Batch #4
Before
crosslinking
after
crosslinking

after
3 months
immersion
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Figure A.1.4 Dimensions (a) and weights (b) for genipin 10% crosslinked samples after
1 month, 2 months and 3 months of incubation.
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Table A.1.4 Dimensions and Weights for Genipin 10% Crosslinked Mat

Batch #1
Before
crosslinking
After
crosslinking
( Omonth)
Batch #2
Before
crosslinking
after
crosslinking

After
1 month
immersion
Batch #3
Before
crosslinking
after
crosslinking

After
2 month
immersion
Batch #4
Before
crosslinking
after
crosslinking

After
3 month
immersion
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Figure A.1.5 Dimensions (a) and weights (b) for EDC crosslinked samples after 1 month,
2 months and 3 months of incubation.
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Table A.1.5 Dimensions and Weights for EDC Crosslinked Mat

Batch #1
Before
crosslinking
After
crosslinking
( Omonth)
Batch #2
Before
crosslinking
after
crosslinking

After
1 month
immersion
Batch #3
Before
crosslinking
after
crosslinking

After
2 month
immersion

Batch #4
Before
crosslinking
after
crosslinking

after
3 months
immersion
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Figure A.1.6 Dimensions (a) and weights (b) for EDC with NHS crosslinked samples
after 1 month, 2 months and 3 months of incubation.
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Table A.1.6 Dimensions and Weights for EDC with NHS Crosslinked Mat

Batch #1
Before
crosslinking
After
crosslinking
( Omonth)

Batch #2
Before
crosslinking

after
crosslinking

After
1 month
immersion

Batch #3
Before
crosslinking

after
crosslinking

After
2 month
immersion

Batch #4
Before
crosslinking
after
crosslinking

after
3 months
immersion
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A.2 Free Amino-Acid Count

The free amino-acid was counted as a measure for crosslinking extent for various
crosslinked mats. N=5 for all the crosslinked samples at each time point.

Figure A.2.1 Free amino-acid count for genipin 5% crosslinked mat after no incubation
(0 month), 1 month, 2 months and 3 months of incubation.

Figure A.2.2 Free amino-acid count for genipin 10% crosslinked mat after no incubation
(0 month), 1 month, 2 months and 3 months of incubation.
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Figure A.2.3 Free amino-acid count for EDC crosslinked mat after no incubation (0
month), 1 month, 2 months and 3 months of incubation.

Figure A.2.3 Free amino-acid count for EDC with NHS crosslinked mat after no
incubation (0 month), 1 month, 2 months and 3 months of incubation.
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A.3 SEM Images and Fiber Diameter Analysis
The SEM images were analyzed using imageJ software online and the fiber diameter of
crosslinked and incubated samples was compared to control to obtain the percent change
in fiber diameter. N=1 for all the crosslinked samples at each time-point.
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(a)

(b)

Figure A.3.1a SEM image of uncross linked, electrospun collagen scaffold at 3KX
magnification.
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(c)

(d)

Figure A.3.th SEM image of uncross linked, electrospun collagen scaffold at lKX (c)
and 3KX (d) magnification.
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Table A.3.1a Fiber Diameter for Uncrosslinked Collagen Fiber Scaffold
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Table A.3.1b Fiber Diameter for Uncrosslinked Collagen Fiber Scaffold (continued)
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Table A.3.2 Fiber Diameter for Glutaraldehyde Control Mat

1
2
3
4
5
Mean
SD
Min
Max

Mean
115.579
117.478
104.055
96.571
122.615
111.26
10.653
96.571
122.615

(a)

Min
101.222
113
93
93.152
111
102.275
9.507
93
113

Max
126.667
126.704
111.129
103.333
128.27
119.221
11 .305
103.333
128.27

Angle
-90
-90
-90
0
0
-54
49.295
-90
0

Length
5.294
2.353
2.706
2.941
1.882
3.035
1.324
1.882
5.294

(b)

Figure A.3.2 SEM image for glutaraldehyde control (a) and glutaraldehyde crosslinked
sample (b).
\

I
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Table A.3.3a Fiber Diameter for Genipin 1% Control Mat and Crosslinked Mat
Glutaraldehyde Control

Genipin1-01

Genipin1-0
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Table A.3.3b Fiber Diameter for Genipin 1% Crosslinked Mat and Percent Increase in

Fiber Diameter
Genipin1-02

Mean

I

Min

I

Max

I Angle I Length

Mean

IMin

I

Max

I Angle I Length

Genioin1-03

Average
Average Length

sample

fiber diameter

% change in fiber diameter

Control

2.54

0 month

6.01

136.61
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(a)

(b)
\

\

Figure A.3.3 SEM image for genipin 1% control (a) and genipin 1% crosslinked sample
(b) before incubation.
I

----------------------------------------

---------------------~~
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Table A.3.4a Fiber Diameter for Genipin 5% Control Mat and Crosslinked Mat Without

Incubation

Genipin05

Genip06
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Table A.3.4b Fiber Diameter for Genipin 5% Mat after 1 Month of Incubation and

Percent Change in Fiber Diameter
G5-10

G5-19

Average
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(a)

(b)

(c)

(d)

\

I

(e)

Figure A.3.4 SEM image for genipin 5% control (a), genipin 5% crosslinked sample (b)
before incubation, genipin 5% crosslinked sample after 1 month (c), 2 months (d) and 3
months (e) of incubation.

-----------------------------------------------------~
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Table A.3.5a Fiber Diameter for Genipin 10% Control Mat and Crosslinked Mat Without
Incubation

G10-01

G10-03
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Table A.3.5a Fiber Diameter for Genipin 10% Control Mat and Crosslinked Mat Without
Incubation (continued)

Average

98

Table A.3.5b Fiber Diameter for Genipin 10% Crosslinked Mat after 1 Month of
Incubation
G5-10

G5-19

Average
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Table A.3.5c Fiber Diameter for Genipin 10% Crosslinked Mat after 2 Months of

Incubation

Genipin 10-20

Genipin 10-28

Average

Genipin10-32

100

Table A.3.5d Fiber Diameter for Genipin 10% Crosslinked Mat after 3 Months of
Incubation And Percent Change in Fiber Diameter

GeniDin 10-33

Average
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(a)

(b)

(c)

\

\

(e)

Figure A.3.S SEM image for genipin 10% control (a), genipin 10% crosslinked sample
(b) before incubation, genipin 10% crosslinked sample after 1 month (c), 2 months (d)
and 3 months (e) of incubation.

----------------~
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Table A.3.6a Fiber Diameter for EDC Control Mat and Crosslinked Mat Without
Incubation

EDC-02

EDC-03
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Table A.3.6a Fiber Diameter for EDC Control Mat and Crosslinked Mat Without
Incubation (continued)
Average
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Table A.3.6b Fiber Diameter for EDC Crosslinked Mat after 1 Month of Incubation
EDC-1-04

EDC-10

EDC-11

Average
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Table A.3.6c Fiber Diameter for EDC Crosslinked Mat after 2 Months of Incubation
EDC-23

EDC-24

EDC-26

Average
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Table A.3.6d Fiber Diameter for EDC Crosslinked Mat after 3 Months of Incubation
EDC-35

EDC-36

EDC-37

Average
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Table A.3.6e Percent Change in Fiber Diameter of EDC Crosslinked Mat Over
Incubation for 3 Months

Time
Control
0 month
1 month
2 month
3 months

Fiber diameter
2.14
2.58
3.79
2.95
1.78

% increase in diameter
0
20.44
76.93
37.72
-16.9
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(a)

(b)

(d)

(c)

"
I

\ I

(e)

Figure A.3.6 SEM image fo~' ED'C control (a), EDC crosslink~d sarnple (b) before
incubation, EDC crosslinked sample after 1 month (c), 2 months (d) and 3 months (e) of
incubation.

------------------------------------------------~-----------------~
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Table A.3.7a Fiber Diameter for EDC with NHS Control Mat and Crosslinked Mat
Without Incubation

NHS-06

NHS-07
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Table A.3.7b Fiber Diameter for EDC with NHS Crosslinked Mat Without Incubation
NHS-08

Average
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Table A.3.7c Fiber Diameter for EDC with NHS Crosslinked Mat after 1 Month of
Incubation
NHS-10

NHS-11

Average

112

Table A.3.7d Fiber Diameter for EDC with NHS Crosslinked Mat after 2 Months of
Incubation
NHS-21

NHS-22

NHS-24

Average
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Table A.3.7e Fiber Diameter for EDC with NHS Crosslinked Mat after 3 Months of
Incubation And Percent Change in Fiber Diameter
NHS-34

NHS-35

Average

114

(a)

(b)

(c)

(d)

\ '

.'

.

(e)

Figure A.3.7 SEM image for EDC with NHS control (a), EDC with NHS crosslinked
sample (b) before incubation, EDC with NHS crosslinked sample after 1 month (c), 2
months (d) and 3 months (e) of incubation.

APPENDIX B
DSC PLOTS

Differential Scanning Calorimetric analysis provides an understanding of the structural
changes occurring in collagen when subjected to thermal heating and stress.

Figure B.1 DSC plot for uncrosslinked electrospun collagen scaffold.

Figure B.2 DSC plot for glutaraldehyde control.
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Sample Genipin control
DSC
Size: 4.0000 mg
Method: Heat/Cool/Heat
Comment The callagen gen soaked in ethanol for 3 days at 37C:

Figure B.3 DSC plot for genipin control.

Figure B.4 DSC plot for EDC control.

File: C.:...\Control\Genipin control.002
Operator: Pallevi
Run Date: 14-Apr-2008 1221
Instrument' DSC 0100 V9.8 Build 296
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Figure B.5 DSC plot for EDC with NHS control.

Figure B.6 DSC plot for glutaraldehyde crosslinked collagen scaffold without
incubation.
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Figure B.7 DSC plot for genipin 1% crosslinked collagen scaffold without incubation.

Figure B.8 DSC plot for genipin 5% crosslinked collagen scaffold without incubation.
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Figure B.9 DSC plot for genipin 10% crosslinked collagen scaffold without incubation.

Figure B.10 DSC plot for EDC crosslinked collagen scaffold without incubation.
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Figure B.11 DSC plot for EDC with NHS crosslinked collagen scaffold without
incubation.

Figure B.12 DSC plot for genipin 5% crosslinked collagen scaffold after 1 month of
incubation in PBS at 37°C.
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Figure B.13 DSC plot for genipin 10% crosslinked collagen scaffold after 1 month of
incubation in PBS at 37°C.

Figure B.14 DSC plot for EDC crosslinked collagen scaffold after 1 month of incubation
in PBS at 37°C.
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Figure B.15 DSC plot for EDC with NHS crosslinked collagen scaffold after 1 month of
incubation in PBS at 37°C.

Figure B.16 DSC plot for genipin 5% crosslinked collagen scaffold after 2 months of
incubation in PBS at 37°C.
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Figure B.17 DSC plot for genipin 10% crosslinked collagen scaffold after 2 months of
incubation in PBS at 37°C.

Figure B.18 DSC plot for EDC crosslinked collagen scaffold after 2 months of
incubation in PBS at 37°C.
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Figure B.19 DSC plot for EDC with NHS crosslinked collagen scaffold after 2 months of
incubation in PBS at 37°C.

Figure B.20 DSC plot for genipin 5% crosslinked collagen scaffold after 3 months of
incubation in PBS at 37°C.
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Figure B.21 DSC plot for genipin 10% crosslinked collagen scaffold after 3 months of
incubation in PBS at 37°C.

Figure B.22 DSC plot for EDC crosslinked collagen scaffold after 3 months of
incubation in PBS at 37°C.
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Figure B.23 DSC plot for EDC with NHS crosslinked collagen scaffold after 3 months of
incubation in PBS at 37°C.

APPENDIXC
PICTURES OF SAMPLES

The samples as they appeared before crosslinking, after crosslinking, after incubation for
1 month, 2 months and 3 months are 'shown below:

Figure C.l Electrospinning hood used for generate collagen scaffold.

Figure C.2 Uncrosslinked electro spun type I collagen scaffold.
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Figure C.3 Uncrosslinked collagen scaffold cut into small pieces lcm X 1 cm.

Figure C.3 Method used to measure the samples dimensions and weights.

I

/

Figure C.4 Genipin 1% crosslinked sample before (left) and after (right) incubation.

Figure C.S Genipin 10% crosslinked sample before (left) and genipin 5% crosslinked
mat after (right) 3 months incubation. The genipin 5% crosslinked mat looked similar to
genipin 10% crosslinked mat.
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(a)

(b)

(c)
Figure C.6 EDC and EDC with NHS crosslinked samples before incubation (a) and EDC
crosslinked (b), EDC with NHS crosslinked (c) samples after 3 months of incubation.
,I

f
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